![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.biospace.com/article/releases/viewpoint-molecular-targeting-announces-transformational-merger/?s=79
https://www.biospace.com/article/releases/viewpoint-molecular-targeting-r-announces-publication-of-preclinical-data-of-vmt01-in-peer-reviewed-journal-cancers-/
https://www.biospace.com/article/releases/viewpoint-molecular-targeting-tm-receives-fda-clearance-of-investigational-new-drug-application-for-phase-1-imaging-study-for-vmt-a-net-for-neuroendocrine-tumors/?s=85
https://www.accesswire.com/651233/Viewpoint-Molecular-TargetinTM-Commences-Patient-Enrollment-in-Phase-1-Imaging-Study-for-VMT01-Program-for-Metastatic-Melanoma